Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
D 7.99 2.04% 0.16
ETON closed down 2.49 percent on Thursday, April 22, 2021, on 82 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical ETON trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 2.04%
200 DMA Support Bullish -0.50%
MACD Bullish Centerline Cross Bullish -0.50%
200 DMA Support Bullish 3.10%
Calm After Storm Range Contraction 3.10%
Down 3 Days in a Row Weakness 3.10%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.30%
Inside Day Range Contraction 2.30%
Overbought Stochastic Strength 2.30%
Fell Below 50 DMA Bearish -1.11%
Older End-of-Day Signals for ETON ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 11 minutes ago
Up 2% 11 minutes ago
Up 1% 11 minutes ago
10 DMA Support about 20 hours ago
Down 3% about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eton Pharmaceutcials, Inc. Description

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Pain Ophthalmic Pain Management Seizure Mimics Ophthalmic Product Ophthalmic Products Allergic Conjunctivitis Liquid Products Parenteral Nutrition Pharmaceutical Product

Is ETON a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.3
52 Week Low 4.325
Average Volume 177,760
200-Day Moving Average 7.72
50-Day Moving Average 8.07
20-Day Moving Average 7.50
10-Day Moving Average 7.80
Average True Range 0.48
ADX 22.04
+DI 21.23
-DI 11.71
Chandelier Exit (Long, 3 ATRs ) 7.15
Chandelier Exit (Short, 3 ATRs ) 8.20
Upper Bollinger Band 8.31
Lower Bollinger Band 6.69
Percent B (%b) 0.7
BandWidth 21.65
MACD Line 0.02
MACD Signal Line -0.07
MACD Histogram 0.0947
Fundamentals Value
Market Cap 189.59 Million
Num Shares 24.2 Million
EPS -3.07
Price-to-Earnings (P/E) Ratio -2.55
Price-to-Sales 372.41
Price-to-Book 138.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.36
Resistance 3 (R3) 8.39 8.25 8.27
Resistance 2 (R2) 8.25 8.12 8.23 8.24
Resistance 1 (R1) 8.04 8.03 7.97 8.01 8.21
Pivot Point 7.90 7.90 7.87 7.88 7.90
Support 1 (S1) 7.69 7.77 7.62 7.66 7.45
Support 2 (S2) 7.55 7.68 7.53 7.42
Support 3 (S3) 7.34 7.55 7.39
Support 4 (S4) 7.31